394 related articles for article (PubMed ID: 36773431)
21. Erastin synergizes with cisplatin via ferroptosis to inhibit ovarian cancer growth in vitro and in vivo.
Cheng Q; Bao L; Li M; Chang K; Yi X
J Obstet Gynaecol Res; 2021 Jul; 47(7):2481-2491. PubMed ID: 33882617
[TBL] [Abstract][Full Text] [Related]
22. Downregulated expression levels of USP46 promote the resistance of ovarian cancer to cisplatin and are regulated by PUM2.
Xu L; Zhang B; Li W
Mol Med Rep; 2021 Apr; 23(4):. PubMed ID: 33576437
[TBL] [Abstract][Full Text] [Related]
23. circRNA circSnx12 confers Cisplatin chemoresistance to ovarian cancer by inhibiting ferroptosis through a miR-194-5p/SLC7A11 axis.
Qin K; Zhang F; Wang H; Wang N; Qiu H; Jia X; Gong S; Zhang Z
BMB Rep; 2023 Mar; 56(2):184-189. PubMed ID: 36617466
[TBL] [Abstract][Full Text] [Related]
24. Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer.
Shin D; Kim EH; Lee J; Roh JL
Free Radic Biol Med; 2018 Dec; 129():454-462. PubMed ID: 30339884
[TBL] [Abstract][Full Text] [Related]
25. Manganese-deposited iron oxide promotes tumor-responsive ferroptosis that synergizes the apoptosis of cisplatin.
Cheng J; Zhu Y; Xing X; Xiao J; Chen H; Zhang H; Wang D; Zhang Y; Zhang G; Wu Z; Liu Y
Theranostics; 2021; 11(11):5418-5429. PubMed ID: 33859755
[No Abstract] [Full Text] [Related]
26. Matrine induces ferroptosis in cervical cancer through activation of piezo1 channel.
Jin J; Fan Z; Long Y; Li Y; He Q; Yang Y; Zhong W; Lin D; Lian D; Wang X; Xiao J; Chen Y
Phytomedicine; 2024 Jan; 122():155165. PubMed ID: 37922791
[TBL] [Abstract][Full Text] [Related]
27. HMOX1 regulates ferroptosis via mic14 and its impact on chemotherapy resistance in small-cell lung cancer.
Sun Y; Zhang J
Anticancer Drugs; 2024 Jun; 35(5):397-411. PubMed ID: 38527419
[TBL] [Abstract][Full Text] [Related]
28. [Effects of Zengmian Yiliu Recipe combined cisplatin on the tumor inhibition rate in platinum-resistant ovarian cancer].
Qi C; Zhang QH; Li JX
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Jun; 32(6):817-21. PubMed ID: 22978111
[TBL] [Abstract][Full Text] [Related]
29. Hedyotis diffusa injection induces ferroptosis via the Bax/Bcl2/VDAC2/3 axis in lung adenocarcinoma.
Huang F; Pang J; Xu L; Niu W; Zhang Y; Li S; Li X
Phytomedicine; 2022 Sep; 104():154319. PubMed ID: 35853302
[TBL] [Abstract][Full Text] [Related]
30. HMOX1 silencing prevents doxorubicin-induced cardiomyocyte injury, mitochondrial dysfunction, and ferroptosis by downregulating CTGF.
Qian J; Wan W; Fan M
Gen Thorac Cardiovasc Surg; 2023 May; 71(5):280-290. PubMed ID: 36008747
[TBL] [Abstract][Full Text] [Related]
31. Frizzled-7 Identifies Platinum-Tolerant Ovarian Cancer Cells Susceptible to Ferroptosis.
Wang Y; Zhao G; Condello S; Huang H; Cardenas H; Tanner EJ; Wei J; Ji Y; Li J; Tan Y; Davuluri RV; Peter ME; Cheng JX; Matei D
Cancer Res; 2021 Jan; 81(2):384-399. PubMed ID: 33172933
[TBL] [Abstract][Full Text] [Related]
32. Reversal of cisplatin resistance by microRNA-139-5p-independent RNF2 downregulation and MAPK inhibition in ovarian cancer.
Chen Y; Cao XY; Li YN; Qiu YY; Li YN; Li W; Wang H
Am J Physiol Cell Physiol; 2018 Aug; 315(2):C225-C235. PubMed ID: 29719173
[TBL] [Abstract][Full Text] [Related]
33. Regulation of Hippo/YAP signaling pathway ameliorates cochlear hair cell injury by regulating ferroptosis.
Niu X; Han P; Liu J; Chen Z; Ma X; Zhang T; Li B; Ma X
Tissue Cell; 2023 Jun; 82():102051. PubMed ID: 36889225
[TBL] [Abstract][Full Text] [Related]
34. MAP30 protein from Momordica charantia is therapeutic and has synergic activity with cisplatin against ovarian cancer in vivo by altering metabolism and inducing ferroptosis.
Chan DW; Yung MM; Chan YS; Xuan Y; Yang H; Xu D; Zhan JB; Chan KK; Ng TB; Ngan HY
Pharmacol Res; 2020 Nov; 161():105157. PubMed ID: 32814169
[TBL] [Abstract][Full Text] [Related]
35. Expression of Ferredoxin1 in cisplatin‑resistant ovarian cancer cells confers their resistance against ferroptosis induced by cisplatin.
Takahashi R; Kamizaki K; Yamanaka K; Terai Y; Minami Y
Oncol Rep; 2023 Jun; 49(6):. PubMed ID: 37144519
[TBL] [Abstract][Full Text] [Related]
36. Potent nanoreactor-mediated ferroptosis-based strategy for the reversal of cancer chemoresistance to Sorafenib.
Wang X; Zhao L; Wang C; Wang L; Wu H; Song X; Wang W; Xu H; Dong X
Acta Biomater; 2023 Mar; 159():237-246. PubMed ID: 36736851
[TBL] [Abstract][Full Text] [Related]
37. TRIAP1 Inhibition Activates the Cytochrome c/Apaf-1/Caspase-9 Signaling Pathway to Enhance Human Ovarian Cancer Sensitivity to Cisplatin.
Zhang TM
Chemotherapy; 2019; 64(3):119-128. PubMed ID: 31661694
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of the IGF signaling pathway reverses cisplatin resistance in ovarian cancer cells.
Du J; Shi HR; Ren F; Wang JL; Wu QH; Li X; Zhang RT
BMC Cancer; 2017 Dec; 17(1):851. PubMed ID: 29241458
[TBL] [Abstract][Full Text] [Related]
39. Dihydrodiol dehydrogenases regulate the generation of reactive oxygen species and the development of cisplatin resistance in human ovarian carcinoma cells.
Chen J; Adikari M; Pallai R; Parekh HK; Simpkins H
Cancer Chemother Pharmacol; 2008 May; 61(6):979-87. PubMed ID: 17661040
[TBL] [Abstract][Full Text] [Related]
40. Effects of microRNA-1271 on ovarian cancer via inhibition of epithelial-mesenchymal transition and cisplatin resistance.
Chen Y; Wang L; Zhou J
J Obstet Gynaecol Res; 2019 Nov; 45(11):2243-2254. PubMed ID: 31411791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
